Jennifer Hughes - Concepedia

Author

Jennifer Hughes

University of Cape Town ORCID

Also Known As

Hughes, Jennifer, J Harris, J Hughes, J. Hughes, Jennifer A Hughes, Jennifer A. Hughes, Jennifer Hughes, Paul Hayden

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

University of Cape Town Médecins Sans Frontières Desmond Tutu HIV Foundation Stellenbosch University University of the Witwatersrand

About

Jennifer Hughes is an author at University of Cape Town specializing in medicine, tuberculosis, and tuberculosis prevention.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	747
2	Public Health	6	6	440
3	Nursing	2	2	96
4	Engineering	1	1	64
5	Health Sciences	1	1	12

Jennifer Hughes

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study Kathryn Schnippel, Norbert Ndjeka, Gary Maartens, The Lancet Respiratory Medicine Retrospective Cohort StudyPulmonary TuberculosisSouth African PatientsTuberculosis PreventionClinical Epidemiology	2018	259
Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis Norbert Ndjeka, Francesca Conradie, Kathryn Schnippel, The International Journal of Tuberculosis and Lung Disease	2015	136
Early safety and efficacy of the combination of bedaquiline and delamanid for the treatment of patients with drug-resistant tuberculosis in Armenia, India, and South Africa: a retrospective cohort study Gabriella Ferlazzo, Erika Mohr-Holland, Chinmay Laxmeshwar, The Lancet Infectious Diseases Pulmonary TuberculosisMedicineTuberculosis PreventionSouth AfricaTuberculosis	2018	134
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen Norbert Ndjeka, Kathryn Schnippel, Iqbal Master, European Respiratory Journal	2018	128
Preventive Therapy for Child Contacts of Multidrug-Resistant Tuberculosis: A Prospective Cohort Study James A. Seddon, A C Hesseling, Heather Finlayson, Clinical Infectious Diseases	2013	107
Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa Helen Cox, Jennifer Hughes, Johnny Daniels, The International Journal of Tuberculosis and Lung Disease	2014	91
Impact of Decentralized Care and the Xpert MTB/RIF Test on Rifampicin-Resistant Tuberculosis Treatment Initiation in Khayelitsha, South Africa Helen Cox, Johnny Daniels, Odelia Muller, Open Forum Infectious Diseases Tuberculosis PreventionMedian TttDiagnosticsDrug ResistanceClinical Epidemiology	2015	82
Principles for designing future regimens for multidrug-resistant tuberculosis Grania Brigden, Bern-Thomas Nyang’wa, Philipp du Cros, Bulletin of the World Health Organization	2013	80
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study Norbert Ndjeka, Jonathon R. Campbell, Graeme Meintjes, The Lancet Infectious Diseases	2022	74
False-positive Xpert<SUP>®</SUP> MTB/RIF assays in previously treated patients: need for caution in interpreting results Tom Boyles, Jennifer Hughes, Vivian Cox, The International Journal of Tuberculosis and Lung Disease EngineeringTuberculosis PreventionDiagnosisPathologyDiagnostics	2014	64

Page 1